Medicines for Ireland (MFI) are urging Government to heed recent warnings from GPs and pharmacists nationwide on the growing risk of medicines shortages as inflation,
Medicines for Ireland (MFI) have highlighted the growing risk of medicines shortages as inflation, energy and transport costs continue to rise, and global supply chain
In line with today’s European Commission’s Guidelines on a European Gas Demand Reduction Plan1, Medicines for Europe urges Governments to maintain energy supply to medicines production sites in the event of energy restrictions in Europe.
According to findings commissioned by Medicines for Ireland (MFI) and compiled by IQVIA Ireland generic medicines now account for 57% of the volume of the total prescription market in Ireland.
We are committed to working with key stakeholders to affect real change and reforms that ensure Irish patients receive the best medical treatment in the most affordable way.
